4 nominees · 6 ballot items.
Six proposals are on the agenda: Election of four directors; Advisory Say-on-Pay; Ratification of appointment of RBSM LLP as independent registered public accounting firm for 2025; Increase in authorized shares of common stock; Exculpation of certain officers; and Second Amendment to ENDRA Life Sciences Inc. 2016 Omnibus Incentive Plan.
Election of four director nominees named in the proxy statement to serve one-year terms expiring at the 2026 annual meeting.
Non-binding advisory vote to approve the compensation of named executive officers as disclosed in the proxy statement.
Ratification of the Audit Committee’s appointment of RBSM LLP as the Company’s independent registered public accounting firm for 2025.
Increase the number of authorized shares of common stock from 20,000,000 to 1,000,000,000.
Create a new Article limiting liability of certain officers under DGCL 102(b)(7) and exculpate certain officers from monetary damages.
Increase the pool of authorized shares under the 2016 Plan by 3,200,000 shares and enable awards to Cryptocurrency Advisory Board; amendment to the Plan.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Altium Capital Management LLC | 4.09% | 51,900 | $241K |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 1.37% | 17,405 | $81K |
| 3 | VANGUARD FIDUCIARY TRUST CO | 0.80% | 10,121 | $47K |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 0.29% | 3,673 | $17K |
| 5 | MORGAN STANLEY | 0.28% | 3,546 | $16K |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 0.22% | 2,816 | $13K |
| 7 | UBS Group AG | 0.01% | 140 | $651 |
| 8 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 0.00% | 19 | $88 |
| 9 | UBS Group AG | 0.00% | 12 | $56 |
| 10 | Caitong International Asset Management Co., Ltd | 0.00% | 4 | $19 |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.